Ditchcarbon
  • Contact
  1. Organizations
  2. Certara
Public Profile
Medical Device Manufacturing
US
updated 2 months ago

Certara Sustainability Profile

Company website

Certara, a leading provider of biosimulation and drug development solutions, is headquartered in the United States. Founded in 2008, the company has established itself as a pivotal player in the pharmaceutical and biotechnology industries, focusing on enhancing drug development processes through advanced modelling and simulation technologies. With a strong presence in North America, Europe, and Asia, Certara offers a range of core services, including pharmacokinetics, pharmacodynamics, and regulatory submission support. Their unique approach integrates cutting-edge software and expert consulting, enabling clients to make informed decisions throughout the drug development lifecycle. Recognised for its innovative contributions, Certara has achieved significant milestones, positioning itself as a trusted partner for biopharmaceutical companies aiming to streamline their research and development efforts.

DitchCarbon Score

How does Certara's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

61

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Certara's score of 61 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

77%

Let us know if this data was useful to you

Certara's reported carbon emissions

In 2024, Certara, headquartered in the United States, reported total carbon emissions of approximately 7,073,000 kg CO2e. This figure includes 160,670 kg CO2e from Scope 1 emissions, primarily from fugitive emissions, and 796,480 kg CO2e from Scope 2 emissions, which are mainly attributed to purchased electricity. The majority of their emissions, about 6,145,990 kg CO2e, fall under Scope 3, indicating significant indirect emissions throughout their value chain. Comparatively, in 2023, Certara's total emissions were about 9,010,770 kg CO2e, with Scope 1 emissions at 363,340 kg CO2e and Scope 2 emissions at 816,410 kg CO2e. The Scope 3 emissions for that year were approximately 7,765,850 kg CO2e. This data reflects a notable reduction in total emissions from 2023 to 2024. Certara has set ambitious near-term targets to reduce its Scope 1 and Scope 2 emissions to near zero by 2025. These commitments demonstrate the company's proactive approach to addressing its carbon footprint and aligning with industry standards for climate action. Certara is currently committed to these reduction targets, although it has not yet established a net-zero commitment. Overall, Certara's emissions data and climate commitments highlight its ongoing efforts to mitigate climate impact and contribute to sustainability within the software and services sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202220232024
Scope 1
441,770
000,000
000,000
Scope 2
1,127,010
000,000
000,000
Scope 3
-
0,000,000
0,000,000

How Carbon Intensive is Certara's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Certara's primary industry is Medical Device Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Certara's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Certara is in US, which has a low grid carbon intensity relative to other regions.

Certara's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Certara has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Certara's Emissions with Industry Peers

Cadence Design Systems

US
•
Computer and related services (72)
Updated 4 days ago

Genomenon, Inc.

US
•
Computer and related services (72)
Updated 12 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Cyrus Biotechnology, Inc.

US
•
Computer and related services (72)
Updated 3 days ago

Optibrium, Ltd.

GB
•
Computer and related services (72)
Updated 11 days ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 21 hours ago

Frequently Asked Questions

Common questions about Certara's sustainability data and climate commitments

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251114.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
AWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy